Saturday 17 October 2026
Export SCL’s income statement to Excel — free account
Stepan Company
SCL Basic Materials Specialty Chemicals
Stepan Company’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 6.96% from fiscal 2024. In the quarter to June 2026, revenue grew 15.0%, EPS grew 100.0%, free cash flow fell 4.42% and total debt fell 1.62%, each against the same quarter a year earlier. Dividend growth for ten consecutive years.
62.03
0.16
+0.26%
Follow SCL
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
24.09 | 23.10 | 0.00 | 0.00 |
P/S ratio |
0.47 | 0.46 | 0.49 | 0.52 | |
P/FCF ratio |
30.88 | 19.62 | 17.06 | 19.20 | |
P/Operating CF |
15.64 | 18.06 | 67.55 | 152.54 | |
P/B ratio |
0.88 | 0.87 | 0.96 | 1.05 | |
Price to Tangible BV |
0.99 | 0.97 | 1.08 | 1.18 | |
EV/Sales |
0.71 | 0.68 | 0.71 | 0.74 | |
EV/EBITDA |
8.24 | 7.71 | 12.70 | 12.13 | |
EV/Operating CF |
10.42 | 10.67 | 10.48 | 11.67 | |
EV/FCF |
46.07 | 28.56 | 24.67 | 27.24 | |
Quick Ratio |
0.78 | 0.78 | 0.80 | 0.72 | |
Current Ratio |
1.30 | 1.29 | 1.26 | 1.15 | |
Net Debt/EBITDA |
9.84 | 11.43 | (30.64) | 7.83 | |
Debt/Assets |
26.95% | 26.58% | 27.93% | 27.06% | |
Debt/Equity |
0.53 | 0.50 | 0.55 | 0.53 | |
Asset Turnover |
0.95 | 1.00 | 0.99 | 1.01 | |
Operating CF/Net income |
6.44 | 11.99 | (0.41) | 0.37 | |
Capex/Depreciation |
(0.90) | (0.25) | (0.94) | (0.76) | |
Interest Coverage |
3.20 | 1.85 | (9.90) | 6.55 | |
Research and Development Expense of Revenue |
2.41% | 2.84% | 2.48% | 2.51% | |
Selling, General and Administrative Expense of Revenue |
5.93% | 6.31% | 5.63% | 5.92% | |
Intangible Assets out of Total Assets |
0.06 | 0.06 | 0.06 | 0.05 | |
Share Based Compensation of Revenue |
0.24% | 0.28% | 0.25% | 0.31% | |
Graham Net Nets |
(0.24) | (0.24) | (0.20) | (0.16) | |
Graham Number |
49.28 | 50.09 | 0.00 | 0.00 | |
Earnings Yield |
4.15% | 4.33% | (1.24%) | (0.22%) | |
Free Cash Flow Yield |
3.24% | 5.10% | 5.86% | 5.21% | |
Revenue per Share |
25.80 | 24.22 | 26.41 | 29.88 | |
Operating CF per Share |
3.05 | 2.62 | 0.74 | 0.37 | |
Capex per Share |
(1.29) | (0.35) | (1.35) | (1.02) | |
Free Cash Flow per Share |
1.76 | 2.27 | (0.61) | (0.66) | |
Cash per Share |
5.18 | 5.80 | 6.15 | 4.97 | |
Shareholders Equity per Share |
54.50 | 54.39 | 52.12 | 52.93 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
54.50 | 54.39 | 52.12 | 52.93 | |
Free Cash Flow |
40.21 | 51.96 | (13.95) | (15.04) | |
Working Capital |
211.25 | 192.47 | 185.79 | 127.77 | |
Capital Expenditures |
(29.55) | (8.03) | (30.89) | (23.41) | |
Net Current Asset Value |
(264.91) | (254.73) | (234.07) | (205.86) | |
EV/EBIT |
21.50 | 20.08 | 2,591.03 | 91.00 | |
Capex to Sales |
0.05 | 0.01 | 0.05 | 0.03 | |
Price to Operating Income |
14.41 | 13.79 | 1,790.77 | 64.16 | |
| Other line items | |||||
Average Receivables |
435.14 | 387.99 | 435.09 | 467.25 | |
Average Payables |
273.22 | 260.26 | 291.92 | 301.71 | |
Average Inventory |
310.49 | 293.77 | 299.17 | 326.97 | |
Average Assets |
2,423.04 | 2,331.18 | 2,361.51 | 2,404.40 | |
Average Common Equity |
1,233.07 | 1,206.97 | 1,196.78 | 1,226.88 |
Columns are period end dates